Eaton Vance Tax Advantaged Dividend EVT

$24.35 +0.01 (0.06%)

Valuation

Market cap
—
Revenue TTM
$-32,078,516
Net income TTM
$-33,442,800
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
8,814
Avg volume
107,520
Day's range
$24.35 – $24.50
Shares out
—
Stochastic %K
10%
Beta
—
Analysts
Strong Sell
Price target
$29.00

Price

Company profile

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks...

Show more

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

Industry
Asset Management
Sector
Financial Services
Phone
617 482 8260
Website
https://funds.eatonvance.com/Tax-Advantaged-Dividend-Income-Fund-EVT.php
Address
One Post Office Square, Boston, United States

Latest news

Stocktwits

Ali_G_and_Doge Sep 23, 9:07 PM
$EVT out may short
1 replies
SuperGreenToday Jun 16, 12:55 AM
$EVT
0 replies
Bobear12 May 23, 9:43 PM
$EVT Galectin Therapeutics (NASDAQ: GALT) is presenting new clinical analyses of its Phase 2b NAVIGATE trial for its lead drug, belapectin, at the EASL Congress. The presentations at the European Association for the Study of the Liver focus on preventing esophageal varices and improving liver biomarkers in patients with MASH cirrhosis.
0 replies
munboxfinance May 21, 4:00 PM
Quick Note: > To put some skin in the game, the $EVT CEF is currently hovering near its 52-week high of $26.37. However, it is trading at a 9.11% NAV discount and maintains a 7.50% distribution rate. This could be a solid opportunity to park a few bucks just to monitor its price action.
0 replies
9ForMyLostGod Mar 31, 2:58 PM
$EVT Those buys below $24 were shaky, but paying off nicely already
0 replies
PolishPrince23 Mar 18, 7:09 PM
$USA Prince is slowly moving USA over to $EVT . This is his buisness not yours. He still loves America though this is certain.
1 replies
SuperGreenToday Mar 2, 11:27 AM
$EVT
0 replies
BillionerOfKing Feb 3, 2:54 PM
$EVT Current Stock Price: $26.25
0 replies